Plain-English translation of NCT02798705 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study is investigating how cardiac amyloidosis โ a rare condition where misfolded proteins accumulate in the heart โ affects the tiny blood vessels that deliver blood to heart muscle. Researchers want to understand whether these protein deposits damage the smallest blood vessels in the heart, which may explain why some patients experience chest pain and other symptoms. By measuring blood flow in these small vessels, the study aims to better understand how amyloidosis harms the heart and develop better treatments.
People with cardiac amyloidosis often have chest pain and signs of reduced blood flow to the heart, even though their major arteries are not blocked. This study exists because doctors don't yet fully understand how the amyloid protein damages the tiny blood vessels in the heart, which is an important first step toward finding new ways to prevent or treat heart damage in these patients.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will undergo specialized heart imaging tests and procedures to measure how well blood flows through the smallest blood vessels in your heart. These tests may include advanced imaging scans and a cardiac catheterization procedure (a thin tube placed in your heart arteries to measure blood flow). The study is enrolling about 30 patients total, and your participation helps researchers understand how amyloidosis damages the heart's blood supply.
AI-generated summary from trial data ยท Jun 4, 2026 ยท Not medical advice
South Korea
Sponsor
Samsung Medical Center
Enrollment target
~30 participants
Started
April 2016
Primary completion
April 2029
Age range
18 Years โ 85 Years
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Joo Myung Lee, MD, MPH, PhD
Samsung Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.